Cravath Publishes Summer 2026 Issue of Alumni Journal
Cravath represented Credit Suisse AG in connection with approximately $470 million of first lien and second lien credit facilities made available to American Bath Group, LLC, a premier manufacturer of bathing products. The facilities consisted of a $325 million first lien term loan facility, a $50 million revolving credit facility and a $95 million second lien term loan facility to be used to finance the acquisition by an affiliate of Lone Star Capital of American Bath Group, LLC, to repay existing debt and for working capital. The transaction closed on September 30, 2016.
The Cravath team included partners Craig F. Arcella and Stephen M. Kessing and associates Isaac C. Beerman, Matthew G. Jones, Joshua Ayal, Zara Bari, Peter H. Webb and Bryan G. Jones on banking matters; partner J. Leonard Teti II and associates Dmitry Zelik, Lingfeng Li, Ashley May and Arvind Ravichandran on tax matters; and associate Peretz Riesenberg on executive compensation and benefits matters. DongHwa Kim also worked on banking matters.
Deals & Cases
July 13, 2026
Cravath represented the agent, mandated lead arrangers and lenders in connection with Boluda Towage’s €2.15 billion (equivalent) term loan facility and €300 million multi‑currency revolving credit facility. The proceeds will be used towards refinancing certain existing credit facilities and for general corporate purposes. Boluda Towage is a leading maritime services operator. The transaction closed on June 30, 2026.
Deals & Cases
April 06, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.
Deals & Cases
February 20, 2026
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.